MCL1 and B-cell acute lymphoblastic leukemia: It should be noted that the combination of BCL-2 (Venetoclax) and MCL-1 (S63845) or BCL-XL (A-1331852) was effective against precursor B-cell acute lymphoblastic leukemia, as reported recently using patients' xenografts in mouse model [70].